![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2005, The Rockefeller University Press Article Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart 1Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Department of Internal Medicine 2Cardiopulmonary Division, Department of Internal Medicine 3Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan 4Department of Developmental Neurobiology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8575, Japan 5Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Saitama 332-0012, Japan Correspondence to Keiichi Fukuda: kfukuda/at/sc.itc.keio.ac.jp Received April 12, 2005; Accepted August 19, 2005. This article has been cited by other articles in PMC.Abstract Arodent cardiac side population cell fraction formed clonal spheroids in serum-free medium, which expressed nestin, Musashi-1, and multi-drug resistance transporter gene 1, markers of undifferentiated neural precursor cells. These markers were lost following differentiation, and were replaced by the expression of neuron-, glial-, smooth muscle cell–, or cardiomyocyte-specific proteins. Cardiosphere-derived cells transplanted into chick embryos migrated to the truncus arteriosus and cardiac outflow tract and contributed to dorsal root ganglia, spinal nerves, and aortic smooth muscle cells. Lineage studies using double transgenic mice encoding protein 0–Cre/Floxed-EGFP revealed undifferentiated and differentiated neural crest-derived cells in the fetal myocardium. Undifferentiated cells expressed GATA-binding protein 4 and nestin, but not actinin, whereas the differentiated cells were identified as cardiomyocytes. These results suggest that cardiac neural crest-derived cells migrate into the heart, remain there as dormant multipotent stem cells—and under the right conditions—differentiate into cardiomyocytes and typical neural crest-derived cells, including neurons, glia, and smooth muscle. Introduction Although the generation of cardiomyocytes in the mammalian heart occurs predominantly during early development, cardiomyocytes in the adult heart are known to proliferate following heart failure or myocardial infarction. Adult cardiac stem cells are self-renewing, clonogenic, and multipotent; they give rise to myocytes, smooth muscle, and endothelial cells to enable the formation of well-differentiated myocardium with blood-carrying new vessels, and myocytes with the characteristics of young cells (Beltrami et al., 2003). Adult heart-derived cardiac progenitor cells expressing stem cell antigen–1 (Sca-1) were shown by Oh et al. (2003) to differentiate into cardiomyocytes in vitro following 5′-azacytidine treatment, and to contribute to the regeneration of damaged myocardium. Although accumulating evidence demonstrates the existence of pluripotent or lineage-committed progenitor cells in the heart, the origin of these cells is unknown. We previously described a method of isolating murine hematopoietic stem cells by dual-wavelength flow cytometric analysis with the fluorescent DNA binding dye Hoechst 33342 (Goodell et al., 1996, 1997; Matsuzaki et al., 2004). This method relies on the differential ability of stem cells to efflux the Hoechst dye, which—like the activity of P-glycoprotein (Zhou et al., 2001)—defines a small subset of side population (SP) cells. SP cells are observed in various tissue types and generally are considered to be tissue-specific progenitor cells. For example, the SP cells in bone marrow are highly enriched for long-term hematopoietic stem cells, and they were also observed in various tissue types (Kim and Morshead, 2003). It is possible that cardiac SP cells represent a cardiac stem/progenitor cell population that can be enriched by the isolation of the Hoechst 33342 effluxing fraction (Hierlihy et al., 2002). Neural stem cells can proliferate in vitro as a floating culture and can generate spheres (neurospheres) in serum-free medium in the presence of EGF, or differentiate into neurons or astrocytes in the absence of EGF (Reynolds and Weiss, 1992). Most cells within neurospheres express nestin and Musashi-1, considered to be markers for undifferentiated neural precursor cells (Lendahl et al., 1990; Sakakibara et al., 1996; Kaneko et al., 2000). In addition to stem cells, Musashi-1 is expressed at least in subsets of astrocytes (Kaneko et al., 2000). The neurosphere culture method is a versatile method for assaying the multipotency of neural stem cells, and for the in vitro expansion of neural stem/progenitor cells (Reynolds and Weiss, 1992). A similar sphere-forming culture method can be applied to tissue-specific stem cells from the retina, pancreas, epidermis, and inner ear, and to neural crest-derived cells (Tropepe et al., 2000; Toma et al., 2001; Zulewski et al., 2001; Li et al., 2003). Common features of sphere formation are the expression of nestin, and the ability of sphere-derived cells to differentiate into other cell types in addition to their own tissue-specific cell type. Because SP cells are dormant, they cannot be expanded readily in vitro. In the present study, the stem cell fraction of the rodent neonatal heart was enriched and expanded using a combination of the SP cell method and the neurosphere-generation method. We identified multilineage potent progenitor cells in the heart that could generate spheres and differentiate into cardiomyocytes and cells with neural crest characteristics, including peripheral nervous system (PNS)-type neurons, glial cells, and smooth muscle cells. We investigated the neural crest cell–like behavior of isolated sphere-derived cells in vivo by transplanting them into chick embryos. Migration of these cells into the heart region contributed to the neural crest-derived dorsal root ganglia, spinal nerves, and aorta, which subsequently differentiated into neurons, glia, and smooth muscle cells. Analysis of transgenic mice hearts expressing protein 0 (P0)-Cre and Floxed-EGFP confirmed that neural crest-derived cells migrate and lay in a dormant, undifferentiated state in the heart expressing nestin and GATA-binding protein 4 (GATA4), or can differentiate into cardiomyocytes or in vitro–derived cardiospheres. Results Isolation and characterization of SP cells in the heart Because adult tissue stem cells can be enriched as SP cells (Goodell et al., 1996, 1997; Matsuzaki et al., 2004), we initially characterized the SP cells in neonatal and adult mouse hearts. FACS analysis demonstrated the presence of cardiac SP cells that are completely blocked by reserpine (Fig. 1
Cardiac SP cells were phenotyped by analysis of cell surface marker expression. Cell suspensions from P2 mouse hearts were treated with Hoechst 33342 and monoclonal antibodies (Abs). Two-dimensional FACS profiles (Fig. 1 Formation of neurosphere-like spheres by cardiac SP cells in serum-free medium SP cells were expanded in culture for further characterization. An investigation of various culture procedures led to the successful application of a method that was used previously to generate neurospheres from cultured central nervous system stem cells to generate neurosphere-like spheres from cardiac SP cells. Using this approach, culture of isolated cardiac SP cells resulted in cell division followed by detachment from the culture plate to form a sphere of proliferating cells referred to as a cardiosphere. Cardiospheres were similar in appearance to neurospheres that were derived from cultured central nervous system stem cells, and formed after 7–10 d in serum-free medium in the presence of EGF and FGF2 (Fig. 1 Neonatal and adult cardiac nonmyocytes contain cardiosphere-initiating cells To investigate the origin of cardiosphere-initiating cells, the nonmyocyte and myocyte-enriched fractions were separated on a Percoll density gradient then assessed in the cardiosphere-forming assay (Reynolds and Weiss, 1992). Percoll-purified neonatal rat or mouse cardiac nonmyocytes were plated at a density of 10,000–20,000 cells/cm2 on uncoated culture dishes (10 cm in diameter). ~50–100 spheres (1–2 spheres/cm2) were observed after 7–14 d in vitro. After dissociation and subculture as single cells, ~10% of the primary sphere-derived cells formed secondary spheres. No primary spheres were observed in cardiomyocyte fractions. These results show that cardiosphere-initiating cells are contained within the nonmyocyte cell populations. We also found that cardiosphere formation can be observed in nonmyocytes prepared from adult (10–24-wk-old) murine hearts. The optimum cell-plating density for formation of cardiospheres was identified as 10,000 cell/ml; most cells that were derived from cardiospheres were positive for nestin and Musashi-1 (unpublished data). This result is consistent with the report by Hulspas et al. (1997) that spheroid colonies displayed clonal growth when murine neural stem cells were cultured at a density of 10,000 cell/ml. We showed that cardiospheres are derived from a single cell from primary cultures plated at 10,000 cell/ml. Primary cell cultures derived from the neonatal hearts of wild-type mice and mice ubiquitously expressing GFP (Okabe et al., 1997) were mixed at a ratio of 9:1. Resultant cardiospheres were GFP-negative or GFP-positive; there was no evidence of mixing of the GFP-positive and GFP-negative cells (unpublished data). Differentiation of cardiosphere-derived cells into multiple cell types in vitro The multipotent capacity of cardiosphere-derived cells was investigated by dissociating cardiospheres to form a single-cell suspension, and then assessing the ability of these cells to differentiate in the absence of EGF and FGF2. Because cardiospheres are similar to neurospheres, the capacity of cardiosphere-derived cells to differentiate into neurons, glial cells, and cardiomyocytes was investigated. At day 0, most cardiosphere-derived cells were positive for nestin and Musashi-1 (Fig. 2, A and C
Cardiosphere differentiation into peripheral nerve cells The ability of cardiospheres to differentiate into cells with PNS characteristics also was examined. Differentiated cardiospheres were immunostained with peripherin, a PNS neuronal marker; p75, a common receptor subunit of the nerve growth factor family that is expressed in sensory neurons, neural crest stem cells (Morrison et al., 1999), and Schwann cells (Stemple and Anderson, 1992); and MAP2, a pan-neuronal marker. A population of small cardiosphere-derived cells with long axons stained positive with all antibody markers (Fig. 3
α-Tubulin promoter (Tα-1)–EYFP transgenic mice, in which all cells with a neuronal lineage express enhanced yellow fluorescent protein (EYFP), were used to evaluate differentiation of cardiosphere-derived cells into neuronal cell types (Sawamoto et al., 2001). Differentiated cardiospheres from Tα-1-EYFP transgenic mice were immunostained with the anti-MAP2 antibody, and revealed expression of MAP2 by the EYFP+ cardiosphere-derived cells (Fig. 3, E and F RT-PCR of MASH1, a proneuronal basic helix-loop-helix protein expressed in immature neuronal cells (Ross et al., 2003); p75; and P0, a Schwann cell myelin marker (Lemke and Axel, 1985; Lemke et al., 1988), also confirmed the differentiation of cardiosphere-derived cells into neuronal cell types (Fig. 3 Cardiosphere differentiation into cardiomyocytes and smooth muscle cells Cardiospheres and cells dissociated from cardiospheres express GATA4, but not Nkx2.5 or muscle enhancement factor 2C, which indicate that these cells are not cardiomyocytes, but their early progenitors (Fig. 4
In the present study, the capacity of cardiosphere-derived cells to differentiate into smooth muscle was investigated by examining the production of α-smooth muscle actin (α-SMA) and calponin (Fig. 4 Cardiosphere cells behave like neural crest cells in vivo At day 0, 99.8% of the cardiosphere-derived cells were nestin+ and Musashi-1+, a characteristic of stem/progenitor cells (Table SI). Following differentiation, the expression of these markers is lost and is replaced by the expression of various markers for differentiation. Many cells were positive for GFAP (68.1 ± 1.8%) and α-SMA (42.9 ± 16.2%), whereas the population of neurons and cardiomyocytes represented 0.45 ± 0.21% and 0.28 ± 0.17% of the total cell population, respectively. Differentiated neurons and cardiomyocytes did not express nestin. The capacity of cardiosphere-derived cells to generate neurons, glia, and smooth muscle cells in culture suggests that they have neural crest-like characteristics. To investigate these characteristics further, we tested the behavior of cardiosphere-derived cells in vivo. Because neural crest cells that originate from the 1–3 somite level contribute to heart structures in the chick embryo, one to three DiI (a lineage tracing dye)-labeled cardiospheres were transplanted into the migration staging area (MSA) between the dorsal neural tube and somite at the first and/or second somite level of Hamburger and Hamilton (1951) stage 9 chicken embryos. DiI-labeled cardiosphere-derived cells were well-dispersed in the embryonic environment 24 h after transplantation (Fig. 5
To facilitate the migration of cardiosphere-derived cells into the heart region, DiI-labeled cardiospheres were transplanted directly onto the lateral pathway between the dorsal somite and the overlying epidermal ectoderm. Again, cardiosphere-derived cells were well-dispersed in the embryonic environment 24 h after transplantation (Fig. 5 To examine the differentiation of transplanted cardiosphere-derived cells in vivo, cardiospheres were prepared from GFP-expressing rat SP cells, because the GFP label allows longer-term identification of individual cells. GFP-labeled cardiospheres were transplanted as described above, and the distribution and differentiation of cardiosphere-derived cells were assessed 2 d later. Many cardiosphere-derived cells formed peripheral ganglia and many also expressed the neuronal marker Hu (Fig. 6
Distribution and differentiation of neural crest-derived cells in the heart For the analysis of the neural crest cell lineage, Yamauchi et al. (1999) generated transgenic mice harboring a Cre gene driven by a promoter of P0, and crossed P0-Cre transgenic mice with CAG-CAT-Z indicator transgenic mice, which carry a lacZ gene downstream of a chicken-actin promoter and a “stuffer” fragment flanked by two loxP sequences. In three different P0-Cre lines crossed with CAG-CAT-Z transgenic (Tg), embryos carrying both transgenes showed lacZ expression in tissues that were derived from neural crest cells, such as spinal dorsal root ganglia, sympathetic nervous system, enteric nervous system, and ventral craniofacial mesenchyme at stages later in development than E9.0. Double Tg mice carrying P0-Cre recombinase and CAG-CAT-EGFP transgenes showed EGFP expression in tissues that were derived from neural crest cells, including spinal dorsal root ganglia, sympathetic nervous system, enteric nervous system, and ventral craniofacial mesenchyme (unpublished data). EGFP+ cells were concentrated at the outflow tract between the aortic and pulmonary arteries and the aortic valves, and at the intramuscular and subepicardial layer of both ventricles, including the intraventricular septum, free wall, and apex (Fig. 7
Discussion Cardiosphere-initiating cells are multipotent The present study used the neurosphere culture method to demonstrate that a certain proportion of SP cells in the heart could proliferate, and that the SP cell–derived cardiosphere-initiating cells were multipotent and could give rise to PNS-type neurons, Schwann cells, smooth muscle cells, and cardiomyocytes. Moreover, cardiosphere-derived cells display characteristics of neural progenitor cells with respect to the expression of nestin, Musashi-1, and p75 (Mujtaba et al., 1998). Hierlihy et al. (2002) reported that cardiac SP cells were progenitor cells for cardiomyocytes. The present study is the first report to demonstrate that cardiac SP cells are cardiomyocyte progenitor cells and neural crest-like multipotent stem/progenitor cells. Recent studies report that adult tissue-specific stem cells have common characteristics (Reynolds and Weiss, 1992; Tropepe et al., 2000; Kawaguchi et al., 2001). First, all express nestin in their immature and multipotential state. Second, they usually are smaller than the major mature cell type. Third, they proliferate and form floating spheres in serum-free medium in the presence of growth factors, and lose their multipotency when cultured in the presence of serum. The present study demonstrated that the characteristics of cardiac SP cell–derived cardiosphere-forming cells are consistent with the common characteristics of tissue-specific stem cells. The present study showed that a portion of the cardiosphere-derived cell population expressed neuron-specific markers. This result is consistent with previous studies that showed that the conduction system of the heart expresses neuron specific markers, including protein gene product 9.5, neurofilament (H, M, and L), HNK1 (chick), tyrosine hydroxylase, Do170, and RMO270 (Verberne et al., 2000; Mueller et al., 2003). To our knowledge, expression of MAP2, peripherin, and Hu has not been demonstrated in the cardiac conduction system. In the present study, the neuron-like cells that were derived from cardiospheres did not stain with anti-myosin antibody. Taken together, the expression profile of the neuron-like cells that were derived from cardiospheres suggests differentiation into neuronal cells, not conduction cells. In the present study, we assessed the characteristics and multipotency of cardiospheres that were derived from P2 neonate mice, and demonstrated the formation of cardiospheres from the adult heart with similar characteristics. Cardiospheres that are derived from adult mice hearts are multipotent, but have several characteristics that distinguish them from cardiospheres that are derived from neonatal mice hearts. First, cardiospheres that are derived from adult hearts form with a greatly reduced efficiency than cardiospheres that are derived from those of neonates. Second, neonatal-derived cardiospheres have a greater capacity than adult-derived cardiospheres to form secondary or tertiary cardiospheres following dissociation. Further characterization of adult-derived cardiospheres is required for any future clinical application. The relationship between cardiosphere-derived cells and neural crest stem cells Neural crest-derived cells have stem cell characteristics because they have the capacity to proliferate and differentiate into various types of cells, including sensory and sympathetic neurons, glial cells in the PNS, and smooth muscle cells in the blood vessels (Le Douarin and Kalcheim, 1999; Hall, 2000; Gammill and Bronner-Fraser, 2003). Because neural crest-derived cells express nestin, Musashi-1, and p75, and can proliferate and differentiate into multiple lineages in vitro, they are regarded as stem cells (Morrison et al., 1999). The heart develops in the neck region, directly beneath the pharyngeal arches; the caudal area of the cranial neural crest is sometimes referred to as the cardiac crest (Kirby, 1989; Osumi-Yamashita et al., 1996). Paracrine factors from cardiac neural crest-derived cells play a potentially crucial role in heart maturation and in the formation of the outflow tract and ventricular septum (Waldo et al., 1999). A recent study in zebra fish demonstrated that the cardiac crest cells also can differentiate into cardiomyocytes (Sato and Yost, 2003). In the present study, transplantation of cardiospheres into chick embryos revealed that these cells migrate by way of dorsolateral pathways to the cardiac outflow tract, and contribute to the smooth muscles of blood vessels and to the PNS, including dorsal root ganglia, sympathetic ganglia, and spinal nerves. The possibility that nonneural crest-derived cells from cardiospheres migrate in the chick embryo is unlikely, because migration is along neural crest-derived cell-specific pathways, and cells are integrated and committed into the neural crest-derived organs. Based on the expression of stem cell markers, multipotency in vitro, and behavior in vivo, it seems that a portion of the cardiosphere-initiating cell population originates from the cardiac crest cells. By lineage analysis using P0-Cre recombinase/Floxed-EGFP double transgenic mice, we also demonstrated that neural crest-derived cells migrated into the myocardium, in addition to the outflow tract and aortic valves; remained in the heart as neural crest-derived cells that could form cardiospheres; and had the capacity to differentiate into various types of cells, including cardiomyocytes. Along similar lines, recent studies report the presence of neural crest stem cells in the postnatal gut that have the capacity to proliferate and differentiate; this suggests that persistence of neural crest stem cells in the adult tissues may help regeneration after injury or disease (Bixby et al., 2002; Kruger et al., 2002). Consistent with these studies, the present study demonstrated that neural crest-derived cells lay dormant in the neonatal heart, expressing nestin. Some of these cells expressed GATA4, but did not express cardiomyocyte-specific proteins, which indicates that they exist as cardiac stem/progenitor cells. An attractive hypothesis is that neural crest-derived cardiosphere-initiating cells that are present in the neonate will remain as the stem cells in the adult heart. Although the present lineage analysis of the neural crest-derived cells and the formation of cardiospheres by neural crest-derived cells support this hypothesis strongly, further investigation using P0-Cre-EGFP double transgenic mice is required. The relation between cardiosphere-initiating cells and other cardiac stem cells Beltrami et al. (2003) reported the existence of stem cells in the adult heart as multipotent CD45−CD34−c-kit+Lin− cells with the capacity to form spheres. In the present study, cardiac SP cells had some characteristics in common with those described by Beltrami et al. (2003), as well as some distinct characteristics. In this study, clonal cardiospheres could differentiate into cardiomyocytes, smooth muscle cells and PNS-type neurons and glial cells, whereas the Lin−c-kit+ cells that were described by Beltrami et al. (2003) only had the capacity to differentiate into endothelial cells, smooth muscle cells, and cardiomyocytes. This discrepancy suggests that cardiosphere-initiating cells can be derived from other cell lineages, including c-kit− cells. Oh et al. (2003) reported the existence of adult heart-derived cardiac progenitor cells expressing Sca-1. According to their analyses, the SP cells in the adult heart were CD45−c-kit− CD34−Sca-1+CD31+CD38+Lin−Flk−Flt−VE-CAD−vWF−, which is in partial agreement with the results that were obtained from neonatal heart SP cells in the present study. The cells of the cardiosphere described in the present study and cardiac Sca-1+ cells share characteristics, but also vary. In the present study, expression of Sca-1 by cardiac SP cells was low or negative. Cardiosphere-derived cells and Sca-1+ cardiomyocyte progenitor cells are distinct cells populations because the cell surface marker, percentage of population, multipotency, and gene expression characteristics are very different. Cai et al. (2003) reported that hearts of mice lacking isl1, a LIM homeodomain transcription factor, are completely missing the outflow tract, right ventricle, and much of the atria, and that isl1 is a marker for a distinct population of undifferentiated cardiac progenitors. Laugwitz et al. (2005) identified isl1+ cardiac progenitors in postnatal rat, mouse, and human myocardium. Co-culture studies with neonatal myocytes indicated that isl1+ cells represent authentic, endogenous cardiac progenitors that display highly efficient conversion to a mature cardiac phenotype. The finding that isl1+ cells did not express Sca-1 and were relatively concentrated at the outflow tract of the heart is consistent with the findings for SP cell derived-cardiosphere forming cells. isl1+ cells were observed only at the looping heart, whereas we observed EGFP+ cells from P0-Cre/EGFP mice in neural crest-derived tissues. Thus, cardiosphere-forming cells and isl1+ cells have common and distinct characteristics. Martin et al. (2004) showed that the adult heart contains an Abcg2-positive SP cell population that is capable of proliferation and differentiation, and defined the molecular signature of cardiac SP cells that function as a progenitor cell population for the development, maintenance, and repair of the heart. The multipotency or developmental origin of the cardiac SP cells was not addressed. The present study did address these issues and advanced the characterization of the cardiac SP cell fraction. A portion of the SP cell population could form cardiospheres; differentiate into neurons, glia, smooth muscle cells, and cardiomyocytes; and seemed to originate from the cardiac neural crest. We have used the cardiosphere formation assay to identify and isolate multipotent stem/progenitor cells in the heart, expand them in vitro, and analyze them in vivo. Further analysis of these cells will contribute to the understanding of the mechanisms that underlie cardiac development. The potential use of these cells for clinical organ repair after injury or disease provides a challenging and exciting prospect. Materials and methods Animals 1-d-old neonatal ICR mice and Wistar rats were purchased from Japan CLEA. Tα-1–EYFP Tg mice were generated to express the EYFP under the control of the neuron-specific Tα-1 as described previously (Sawamoto et al., 2001). The P0-Cre recombinase Tg mouse (Yamauchi et al., 1999) was provided by K. Yamamura (Kumamoto University, Kumamoto, Japan). The CAG-CAT-EGFP Tg mouse (Kawamoto et al., 2000) was a gift from J. Miyazaki (Osaka University, Osaka, Japan). All experimental procedures and protocols were approved by the Animal Care and Use Committees of the Keio University and conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Cell preparation Primary cultures of cardiomyocytes and cardiac nonmyocytes were prepared from the ventricles of 1–7-d-old neonatal and adult rats or mice by enzymatic dissociation. The Percoll gradient method was used to separate cardiomyocytes from nonmyocytes as described previously (Sano et al., 2000). Isolation of SP cells and FACS analysis Hoechst 33342 solution (Sigma-Aldrich) was prepared immediately before use. Cells were resuspended at 106 cells/ml, and stained with 6.0 μg/ml of Hoechst 33342 in calcium- and magnesium-free HBSS+ (supplemented with 2% FCS, 10 mM Hepes, and 1% penicillin/streptomycin) medium for 90 min at 37°C. As a negative control for SP cells, 106 cells were stained in the presence of 100 μM reserpine (Sigma-Aldrich) in parallel experiments. Antibody staining For FACS analysis, cells were washed once in cold HBSS+, resuspended at 108 cells/ml, and stained with FITC- or phycoerythrin-conjugated Abs against CD11b, 13, 29, 31, 34, 44, 45, 49b, 49e, 73, and 117 (c-kit), Flk-1, Ter119, and Sca-1 (BD Biosciences) at saturating concentrations. After antibody staining, the cells were washed with an excess amount of HBSS+ and resuspended at 107 cells/ml in HBSS+ containing 2 μg/ml propidium iodide (Sigma-Aldrich). Flow cytometry Cell analysis and sorting was performed on a triple laser FACS Vantage (Becton Dickinson). Hoechst 33342 was excited at 350 nm, and fluorescence emission was detected using a 405/BP30 and 570/BP20 optical filter for Hoechst blue and Hoechst red, and a 550-nm long-pass dichroic mirror (Omega Optical Inc.) to separate the emission wavelengths. Hoechst blue and red emit fluorescence according to a linear scale. Propidium iodide fluorescence was measured through 630BP30 after excitation at 488 nm with an argon laser, and a live cell gate was defined to exclude propidium iodide–positive cells. The SP population was defined as described in previous reports after collecting 105 events (Goodell et al., 1996, 1997; Matsuzaki et al., 2004). Cardiosphere cell culture Cells were suspended at a density of 1–2 × 106 cells/ml in 10-cm uncoated dishes in DME/M199 (1:1) serum-free growth medium containing insulin (25 μg/ml), transferin (100 μg/ml), progesterone (20 nM), sodium selenate (30 nM), putrescine (60 nM) (all from Sigma-Aldrich), recombinant murine EGF (20 ng/ml) (Funakoshi), and recombinant human FGF2 (20 ng/ml) as described previously (Reynolds and Weiss, 1992). Half of the medium was changed every 3 d. Passaging was performed using 0.05% trypsin and 0.53 mM EDTA-4Na every 7–14 d. Cardiospheres were dissociated into a single-cell suspension then reseeded into fresh medium. For monolayer cultures, cardiospheres were dissociated and seeded onto gelatin-coated glass slides in DME/M199 (1:1) containing 0.5–10% FBS in the presence or absence of EGF and FGF2. Half of this medium, referred to as differentiation medium, was changed every 2–4 d. Immunofluorescent staining Cells were cultured on gelatin-coated glass coverslips, fixed with 4% paraformaldehyde/PBS, then incubated with primary Abs against mouse anti-nestin, Rat 401 (Hockfield and McKay, 1985, Hybridoma Bank), anti-MAP2, anti-GFAP, anti-NeuN, anti-sarcomeric myosin MF20, and anti-αSMA (all from Sigma-Aldrich) MoAbs, rat anti–Musashi-1 MoAb, 14H1 (Kaneko et al., 2000), rabbit anti-peripherin (Chemicon) and anti-p75 (Sigma-Aldrich) PoAbs, and human anti-Hu (Okano and Darnell, 1997) MoAb for 12–24 h at 4°C. Cells were incubated with secondary Abs for 2–6 h at room temperature. Secondary Abs were used at the following dilutions: anti–mouse IgG/Texas red (1:500), anti–mouse IgG/FITC (1:100), anti–mouse IgG1/FITC (1:500) (BD Biosciences), anti–mouse IgG2b/Texas red (1:500), anti–mouse IgG/HRP (DakoCytomation), anti–rabbit IgG-PE, and anti-human IgG-Alexa542. The samples were washed twice with PBS, then treated with 0.5 μg/ml DAPI (Sigma-Aldrich) for 2 min. RT-PCR analysis Isolation of RNA and RT-PCR was performed as described previously (Sano et al., 2000). Detection of cardiomyocyte-specific or stem cell marker genes, including nestin, Musashi-1, MDR-1, and p75; neuronal lineage markers, including MAP-2 and MASH1; glia-specific markers, including GFAP and P0; cardiomyocyte markers, including Nkx2.5, GATA4, β-MHC, α-skeletal actin, atrial natriuretic peptide, and α1c subunit of L-type Ca2+ channel; and smooth muscle markers, including calponin and αSMA, was performed using 0.01 μg of total RNA. The primers are listed in Table SII (available at http://www.jcb.org/cgi/content/full/jcb.200504061/DC1). Action potential recording Action potential of the beating cells was recorded in DME/M199 (1:1) medium containing 1.49 mmol/L CaCl2, 4.23 mmol/L KCl, and 25 mmol/L Hepes (pH 7.4), and was performed as described previously (Makino et al., 1999). Transplantation of cardiosphere into chick embryos DiI was made up in 0.5% stock solutions in 100% ethanol, and was diluted in 0.3 M sucrose to 0.5 μg/μl. Cardiospheres were washed in DME/M199, labeled with DiI by for 30 s, and washed three times again in DME/M199. Fertilized chicken (Gallus gallus) eggs were incubated at 38°C. Embryos were staged according to Hamburger and Hamilton (1951). Transplantation procedures essentially were performed as described previously (Wakamatsu et al., 1998). In brief, the medial or lateral pathway of stage 9 or 12–13 host embryos was opened with sharp tungsten needles, and one to three cardiospheres containing ~50–100 cells were inserted with a blunt tungsten needle. Whole-mount images of transplanted embryos were captured with a cooled CCD camera equipped on a fluorescent dissection microscope (MZFLIII, Leica). Fixed embryos were cryosectioned and stained with HNK1 (Tucker et al., 1988), 16A11 anti-Hu (Marusich et al., 1994), anti-GFAP, or anti-SMA Abs. Cell nuclei were counter-stained with DAPI. Immunostaining was performed as described previously (Wakamatsu et al., 1998). Images were captured with cooled CCD camera equipped on a fluorescent microscope (Axio PlanII, Zeiss), and were processed with Adobe Photoshop (v5.0) software. P0-Cre/EGFP mice P0-Cre Tg mice were crossed with CAG-CAT-EGFP indicator Tg mice. Hearts from E17.5 mice were dissected, washed in PBS, embedded in OCT Compound (TED PELLA), and quickly frozen in liquid nitrogen. Cryostat sections (8-μm thick) were stained overnight at 4°C using specific Abs. Anti-GFP (MBL), anti-actinin, anti-GATA4, and anti-nestin Abs were used to identify EGFP+ cells, cardiomyocytes, and hematopoietic cells. The sections were incubated with secondary Abs conjugated with Alexa 488 or 594 (Molecular Probes). Nuclei were stained with Toto-3 (Molecular Probes). Slides were observed under a confocal laser scanning microscope (LSM 510 META; Carl Zeiss Microimaging, Inc.). Online supplemental material Table SI shows temporal changes of the immunofluorescent staining positive cells of the stem cell or differentiation markers. Table S2 shows the PCR primers used in this study. Online supplemental material available at http://www.jcb.org/cgi/content/full/jcb.200504061/DC1. Notes Abbreviations used in this paper: α-SMA, α-smooth muscle actin; Ab, antibody; EYFP, enhanced yellow fluorescent protein; GATA4, GATA-binding protein 4; GFAP, glial fibrillary acidic protein; HNK1, human natural killer-1; MAP2, microtubule-associated protein 2; MASH1, neural-specific helix-loop-helix–type transcription factor; MDR-1, multi-drug resistance transporter gene 1; MHC, myosin heavy chain; atrial natriuretic peptide; MP, main population; MSA, migration staging area; P0, protein 0; PNS, peripheral nervous system; Sca-1, stem cell antigen-1; SP, side population; Tα-1, α-tubulin promoter; Tg, transgenic. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Cell. 2003 Sep 19; 114(6):763-76.
[Cell. 2003]Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12313-8.
[Proc Natl Acad Sci U S A. 2003]J Exp Med. 1996 Apr 1; 183(4):1797-806.
[J Exp Med. 1996]Nat Med. 1997 Dec; 3(12):1337-45.
[Nat Med. 1997]Immunity. 2004 Jan; 20(1):87-93.
[Immunity. 2004]Nat Med. 2001 Sep; 7(9):1028-34.
[Nat Med. 2001]J Neurosci. 2003 Nov 19; 23(33):10703-9.
[J Neurosci. 2003]Science. 1992 Mar 27; 255(5052):1707-10.
[Science. 1992]Cell. 1990 Feb 23; 60(4):585-95.
[Cell. 1990]Dev Biol. 1996 Jun 15; 176(2):230-42.
[Dev Biol. 1996]Dev Neurosci. 2000; 22(1-2):139-53.
[Dev Neurosci. 2000]Science. 2000 Mar 17; 287(5460):2032-6.
[Science. 2000]J Exp Med. 1996 Apr 1; 183(4):1797-806.
[J Exp Med. 1996]Nat Med. 1997 Dec; 3(12):1337-45.
[Nat Med. 1997]Immunity. 2004 Jan; 20(1):87-93.
[Immunity. 2004]Science. 1992 Mar 27; 255(5052):1707-10.
[Science. 1992]Exp Neurol. 1997 Nov; 148(1):147-56.
[Exp Neurol. 1997]FEBS Lett. 1997 May 5; 407(3):313-9.
[FEBS Lett. 1997]Nat Med. 2001 Sep; 7(9):1028-34.
[Nat Med. 2001]Cell. 1999 Mar 5; 96(5):737-49.
[Cell. 1999]Cell. 1992 Dec 11; 71(6):973-85.
[Cell. 1992]J Neurosci Res. 2001 Aug 1; 65(3):220-7.
[J Neurosci Res. 2001]Neuron. 2003 Jul 3; 39(1):13-25.
[Neuron. 2003]Cell. 1985 Mar; 40(3):501-8.
[Cell. 1985]Neuron. 1988 Mar; 1(1):73-83.
[Neuron. 1988]Dev Biol. 1999 Aug 1; 212(1):191-203.
[Dev Biol. 1999]Dev Biol. 1998 Aug 1; 200(1):1-15.
[Dev Biol. 1998]FEBS Lett. 2002 Oct 23; 530(1-3):239-43.
[FEBS Lett. 2002]Science. 1992 Mar 27; 255(5052):1707-10.
[Science. 1992]Science. 2000 Mar 17; 287(5460):2032-6.
[Science. 2000]Mol Cell Neurosci. 2001 Feb; 17(2):259-73.
[Mol Cell Neurosci. 2001]Anat Rec. 2000 Dec 1; 260(4):335-50.
[Anat Rec. 2000]Toxicol Pathol. 2003 Mar-Apr; 31(2):227-34.
[Toxicol Pathol. 2003]Evol Dev. 2000 Jan-Feb; 2(1):3-5.
[Evol Dev. 2000]Nat Rev Neurosci. 2003 Oct; 4(10):795-805.
[Nat Rev Neurosci. 2003]Cell. 1999 Mar 5; 96(5):737-49.
[Cell. 1999]J Clin Invest. 1999 Jun; 103(11):1499-507.
[J Clin Invest. 1999]Dev Biol. 2003 May 1; 257(1):127-39.
[Dev Biol. 2003]Neuron. 2002 Aug 15; 35(4):643-56.
[Neuron. 2002]Neuron. 2002 Aug 15; 35(4):657-69.
[Neuron. 2002]Cell. 2003 Sep 19; 114(6):763-76.
[Cell. 2003]Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12313-8.
[Proc Natl Acad Sci U S A. 2003]Dev Cell. 2003 Dec; 5(6):877-89.
[Dev Cell. 2003]Nature. 2005 Feb 10; 433(7026):647-53.
[Nature. 2005]Dev Biol. 2004 Jan 1; 265(1):262-75.
[Dev Biol. 2004]J Neurosci Res. 2001 Aug 1; 65(3):220-7.
[J Neurosci Res. 2001]Dev Biol. 1999 Aug 1; 212(1):191-203.
[Dev Biol. 1999]FEBS Lett. 2000 Mar 31; 470(3):263-8.
[FEBS Lett. 2000]J Biol Chem. 2000 Sep 22; 275(38):29717-23.
[J Biol Chem. 2000]J Exp Med. 1996 Apr 1; 183(4):1797-806.
[J Exp Med. 1996]Nat Med. 1997 Dec; 3(12):1337-45.
[Nat Med. 1997]Immunity. 2004 Jan; 20(1):87-93.
[Immunity. 2004]Science. 1992 Mar 27; 255(5052):1707-10.
[Science. 1992]J Neurosci. 1985 Dec; 5(12):3310-28.
[J Neurosci. 1985]Dev Neurosci. 2000; 22(1-2):139-53.
[Dev Neurosci. 2000]J Neurosci. 1997 May 1; 17(9):3024-37.
[J Neurosci. 1997]J Biol Chem. 2000 Sep 22; 275(38):29717-23.
[J Biol Chem. 2000]J Clin Invest. 1999 Mar; 103(5):697-705.
[J Clin Invest. 1999]Development. 1998 Nov; 125(21):4205-13.
[Development. 1998]Cell Tissue Res. 1988 Feb; 251(2):457-65.
[Cell Tissue Res. 1988]J Neurobiol. 1994 Feb; 25(2):143-55.
[J Neurobiol. 1994]